15 David Abrams Teva- Pharmaceutical Industries Ltd. Trades
The first Teva- Pharmaceutical Industries Ltd. trade was made in Q3 2011. Since then David Abrams bought shares four more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2022 and Q1 2024.
Avg closing price
Price range
Sold -6 Million shares
Q1 2024
Avg closing price
$12.61
Price range
$10.67
-
$14.43
Sold 24.7% shares (-1.97 Million shares)
Q4 2023
Avg closing price
$9.34
Price range
$8.12
-
$10.63
Sold 50.0% shares (-7.97 Million shares)
Q1 2023
Avg closing price
$9.89
Price range
$8.36
-
$11.37
Sold 33.3% shares (-7.97 Million shares)
Q4 2022
Avg closing price
$8.73
Price range
$7.95
-
$9.48
Sold 0.6% shares (-147 Thousand shares)
Q3 2022
Avg closing price
$8.84
Price range
$6.86
-
$11.21
Increased shares by 33.2% (+6 Million shares)
Q3 2019
Avg closing price
$7.66
Price range
$6.16
-
$9.60
Sold 2.6% shares (-476 Thousand shares)
Q1 2019
Avg closing price
$17.63
Price range
$15.58
-
$20.01
Sold 5.1% shares (-1 Million shares)
Q4 2018
Avg closing price
$20.50
Price range
$14.59
-
$23.84
Sold 1.1% shares (-221 Thousand shares)
Q3 2018
Avg closing price
$23.22
Price range
$21.06
-
$25.65
Sold 8.7% shares (-1.88 Million shares)
Q4 2017
Avg closing price
$15.04
Price range
$11.23
-
$19.10
New holding (+21.6 Million shares)
Q3 2017
Avg closing price
$22.50
Price range
$15.41
-
$33.31
Sold -2.56 Million shares
Q3 2013
Avg closing price
$39.00
Price range
$37.43
-
$41.27
Increased shares by 8.8% (+206 Thousand shares)
Q4 2012
Avg closing price
$39.92
Price range
$36.95
-
$42.52
Increased shares by 8.5% (+184 Thousand shares)
Q4 2011
Avg closing price
$39.84
Price range
$35.85
-
$42.72
New holding (+2.17 Million shares)
Q3 2011
Avg closing price
$41.82
Price range
$35.26
-
$49.47
